Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications.
OBJECTIVE
To determine the relation between ASA ingestion and the incidence of bleeding complications after transrectal ultrasound (TRUS)-guided biopsy of the prostate.


METHODS
Overall, 1810 patients with suspected prostate disease were followed after biopsy. ASA use was determined before the procedure. A TRUS-guided sextant biopsy was performed and patients were contacted immediately and by follow-up telephone call to determine whether there were any immediate or delayed bleeding complications.


RESULTS
Overall, 46 subjects (2.5%) had bleeding complications. Of the 54 subjects reporting current use of ASA, 2 (3.7%) had such complications. This difference was not significant.


CONCLUSIONS
There was no evidence of an association between the use of ASA and postbiopsy bleeding complications.
Department of Diagnostic Imaging, Foothills Hospital, Calgary, Alta.
E J
EJ
Herget
J C
JC
Saliken
B J
BJ
Donnelly
R R
RR
Gray
D
D
Wiseman
G
G
Brunet
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D001707:Biopsy, Needle / Q000295:instrumentation*; D019160:Endosonography / Q000295:instrumentation*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000139:chemically induced*; D011446:Prospective Studies; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000473:pathology*; D012007:Rectum; D012307:Risk Factors
D001241:Aspirin